Pituitary Volume and Headache: Size Is Not Everything

Archives of Neurology

Volumn 61, Issue 5, 2004, Pages 721-725

  Levy, Miles J ^a   Jäger, H Rolf ^b   Powell, Michael ^c   Matharu, Manjit S ^a   Meeran, Karim ^d   Goadsby, Peter J ^a,e  

^a Headache Group   (United Kingdom)

^b Department of Radiology ^*  (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER PATIENT; CAVERNOUS SINUS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; FAMILY HISTORY; HEADACHE; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; TUMOR VOLUME;

CAVERNOUS SINUS; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES;

EID: 2442628504     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.5.721     Document Type: Article

References (43)

1. Levy MJ, Jager HR, Matharu MS, Goadsby PJ. Pituitary tumours and headache: does size matter [abstract]? Cephalalgia. 2002;22:592.
2. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43:1678-1683.
3. Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K. Headache associated with pituitary adenomas. Headache. 1998;38:782-786.
4. Suwanwela N, Phanthumchinda K, Kaoropthum S. Headache in brain tumor: a cross-sectional study. Headache. 1994;34:435-438.
5. McNaughton FL. The innervation of the intracranial blood vessels and dural sinuses. Proc Assoc Res Nervous Mental Dis. 1938;18:178-200.
6. Hennessey JV, Jackson IM. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly. Baillieres Clin Endocrinol Metab. 1995;9:271-314.
7. Biermasz NR, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab. 2000;85:4596-4602.
8. Williams G, Ball JA, Lawson RA, Joplin GF, Bloom SR, Maskill MR. Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. BMJ. 1987;295:247-248.
9. Pascual J, Freijares J, Berciano J, Pesquera C. Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Pain. 1991;47:341-344.
10. Musolino NR, Marino-Junior R, Bronstein MD. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995. Clin J Pain. 1990;6:243-245.
11. Sandler LM, Burrin JM, Williams G, Joplin GF, Carr DH, Bloom SR. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clin Endocrinol (Oxf). 1987;26:85-95.
12. Schindler M, Holloway S, Hathway G, Woolf CJ, Humphrey PP, Emson PC. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res. 1998;798:25-35.
13. Lee AH. Pituitary adenoma causing classical migraine. Br J Neurosurg. 1990;4:347-348.
14. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (2nd ed). Cephalalgia. 2004;24(suppl 1):1-160.
15. Porta-Etessam J, Ramos-Carrasco A, Berbel-Garcia A, Martinez-Salio A, Benito-Leon J. Clusterlike headache as first manifestation of a prolactinoma. Headache. 2001;41:723-725.
16. Milos P, Havelius U, Hindfelt B. Clusterlike headache in a patient with a pituitary adenoma: with a review of the literature. Headache. 1996;36:184-188.
17. Massiou H, Launay JM, Levy C, El Amran M, Emperauger B, Bousser M-G. SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology 2002;58:1698-1699.
18. Ferrari MD, Haan J, van Seters AP. Bromocriptine-induced trigeminal neuralgia attacks in a patient with pituitary tumor. Neurology. 1988;38:1482-1484.
19. Gazioglu N, Tanriover N, Tuzgen S. Pituitary tumour presenting with trigeminal neuralgia as an isolated symptom. Br J Neurosurg. 2000;14:579.
20. Gabrielli M, Gasbarrini A, Fiore G, et al. Resolution of migraine with aura after successful treatment of a pituitary microadenoma. Cephalalgia. 2002;22:149-150.
21. Hartman N, Voron SC, Hershman JM. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma). Headache. 1995;35:430-431.
22. Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonist and headache: two case reports. Eur J Neurol. 2003;10:169-174.
23. Lundin P, Pedersen F. Volume of pituitary macroadenomas: assessment by MRI. J Comput Assisted Tomogr. 1992;16:519-528.
24. Cottier JP, Destrieux C, Brunereau L, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215:463-469.
25. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33:610-617.
26. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000;85:1789-1793.
27. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache. 2001;41:854-861.
28. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
29. Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992;42:1225-1231.
30. Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical Practice. 2nd ed. London, England: Martin Dunitz, Taylor & Francis Group Publications; 2002.
31. Peres MF, Sanchez del Rio M, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71:747-751.
32. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935-940.
33. Grouzmann E, Deruaz JP, Gomez F, Waeber G. Immunolocalization of neuropeptide Y in human pituitary tumours. Regul Pept. 1998;75-76:89-92.
34. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
35. Silberstein SD. Migraine and women: the link between headache and hormones. Postgrad Med. 1995;97:147-153.
36. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275-278.
37. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology. 2000;55:1328-1335.
38. Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol. 2002;1:251-257.
39. Leone M, Partuno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia. 1990;10:235-239.
40. May A, Bahra A, Buchel C, Turner R, Goadsby PJ. Functional MRI in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol. 1999;46:791-793.
41. Malick A, Strassman AM, Burstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol. 2000;84:2078-2112.
42. Haan J, Terwindt G, Ferrari MD. Genetics of migraine. Neurol Clin. 1997;15:43-60.
43. Russell MB, Andersson PG, Iselius L. Cluster headache is an inherited disorder in some families. Headache. 1996;36:608-612.